Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pruvanserin in Primary Insomnia
NCT00259311Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pruvanserin in Insomnia (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: Wakening After Sleep Onset. Started Nov 2005; status: completed.
02
Drugs
pruvanserin
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00259311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259311.